SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-067568
Filing Date
2023-03-10
Accepted
2023-03-10 15:58:30
Documents
12
Period of Report
2023-03-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d445917d8k.htm   iXBRL 8-K 25254
  Complete submission text file 0001193125-23-067568.txt   150217

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vera-20230310.xsd EX-101.SCH 2835
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vera-20230310_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vera-20230310_pre.xml EX-101.PRE 11697
6 EXTRACTED XBRL INSTANCE DOCUMENT d445917d8k_htm.xml XML 3484
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40407 | Film No.: 23723509
SIC: 2834 Pharmaceutical Preparations